Abstract:Prostate cancer is one of the most commonly diagnosed cancers worldwide, particularly in elderly populations. To mitigate the expected increase in prostate cancer-related morbidity and mortality as a result of an expanding aged population, safer and more effective therapeutics are required. To this end, plenty of research is focusing on the mechanisms underlying cancer initiation and development, the metastatic process and on the discovery of new therapies. While animal models are used (mainly rats and mice) for the study of prostate cancer, alternative models and methods are increasingly being considered to replace, or at least reduce, the number of animals used in this particular field of research. In this review, we cover some of the alternative models that are currently available for use in the study of prostate cancer, including: mathematical models; 2-D and 3-D cell cultures; microfluidic devices; the chicken egg chorioallantoic membrane-based model; and zebrafish embryo-based models. The main advantages and limitations, as well as some examples of applications, are given for each type of model. According to our analysis, immortalised cell lines are still the most commonly used models in the field of prostate cancer research. However, the use of alternative models for prostate cancer research will likely become more prevalent in the coming years partly because of the increasing societal pressure to reduce the numbers of laboratory animals. In this context, the development and dissemination of effective non-animal alternative models assumes particular relevance and will be instrumental in leveraging their success. Taking these perspectives into account, we believe that technological advances will lead to more effective cell culture systems, namely 3-D cultures or organ-on-a-chip devices, which can be used to replace animal-based models in prostate cancer research.

Current views on in vivo models for breast cancer research and related drug development

In vivo models in breast cancer research: progress, challenges and future directions

Emerging In Vitro and In Vivo Models: Hope for the Better Understanding of Cancer Progression and Treatment

Current Insights in Murine Models for Breast Cancer: Present, Past and Future

Research progress in experimental animal models of breast cancer

Animal models for modeling pancreatic cancer and novel drug discovery

Models of breast cancer: quo vadis, animal modeling?

The past, present, and future of breast cancer models for nanomedicine development

An Overview of Current Alternative Models for Use in the Context of Prostate Cancer Research

State of the Art Modelling of the Breast Cancer Metastatic Microenvironment: Where Are We?

Primary Bone Tumors and Breast Cancer-Induced Bone Metastases: In Vivo Animal Models and New Alternative Approaches

In Vivo Pharmacology Models for Cancer Target Research.

An overview of the latest in state-of-the-art murine models for prostate cancer

Trials, Tribulations, and Trends in Tumor Modeling in Mice

Preclinical Models of Brain Metastases in Breast Cancer

Orthotopic and metastatic tumour models in preclinical cancer research

Mouse models of breast cancer in preclinical research

EURL ECVAM Literature Review Series on Advanced Non-Animal Models for Respiratory Diseases, Breast Cancer and Neurodegenerative Disorders

Bridging the gap between testing and clinics exploring alternative pre-clinical models in melanoma research

Preclinical Molecular Imaging for Precision Medicine in Breast Cancer Mouse Models

Experimental mouse models for translational human cancer research